Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.
By J. Kukowska-Latallo, Kimberly A. Candido, Zhengyi Cao, Shraddha S. Nigavekar, I. Majoros, Thommey P. Thomas, L. Balogh, Mohamed K Khan, J. Baker. Cancer Research, 2005
892 citations recorded by the source corpus.
Subfields: Biomaterials, Molecular Biology, Polymers and Plastics
View Paper: https://www.semanticscholar.org/paper/334e913aecb631e46439cb5421cc703a0337df66
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
- O. Farokhzad
- Robert Langer
- F. Gu
- Juliana M. Chan
- Mohamed Al-Fandi
- J. Fréchet
- J. Andrew MacKay
- T. Yih
In Molecular Biology
- O. Farokhzad
- Robert Langer
- Mohamed Al-Fandi
- J. Fréchet
- J. Andrew MacKay
- T. Yih
- Sameer Quazi
- Tomasz M. Karpinski
In Polymers and Plastics
Citations in the corpus
- Designing dendrimers for biological applications (2005, background): “PAMAM dendrimers have also been used as antitumor targeted carriers of methotrexat”
- Nanomaterials and nanoparticles: Sources and toxicity (2007, background): “Nanoparticles are internalized not only by professional phagocytes such as alveolar macrophages [30], [145], [228], but by various types of cells, including endothelial cells [230], pulmonary epithelium [142], [231-236], gastrointestinal epithelium [204], red blood cells [203], [237], platelets [238”
- Nanoparticles in Medicine: Therapeutic Applications and Developments (2008, background): “Moreover, the targeted, methotrexate-loaded dendrimer had less systemic toxicity than free methotrexate.(35) The promising properties of polyamidoamine dendrimers as a drug delivery system have led to further studies based on tunable architectures and molecular weights to optimize accumulation in tu”
- Nanocarriers as an emerging platform for cancer therapy. (2007, background): “Direct coupling of these targeting agents to nanocarriers containing chemotherapies such as drugs has improved intracellular delivery and therapeutic outcome in animal tumour model”
- Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles (2007, background): “have synthesized folate-conjugated dendrimer nanoparticles coupled to methotrexate.(44) These nanoparticles accumulate in human KB tumors and livers tissue over 4 days after their administration because the liver and KB tumor cells express high levels of the folate receptor.”
- Nanoparticles for Cancer Therapy: Current Progress and Challenges (2021, background): “mAb Nanoparticles Monoclonal antibodies are widely used in cancer treatment for their particular targeting abilities [65].”